Quote:

---

Longing for the day when other people in the world like our betters at the fda see a study and article like this and say "hey sounds like what LL does... maybe we should take a look at that"

Arthritis drug baricitinib may help patients with Type 1 diabetes/

---

Baricitinib is a JAK1 and JAK2 inhibitor. It's exactly what leronlimab does. Leronlimab inhibits JAK1, JAK2 and JAK3. But of course leronlimab also inhibits a much wider array of inflammatory cytokines, so more effective. Rheumatoid arthritis and osteoarthritis are both on the leronlimab disease list as is type 1 and type 2 diabetes.

If anyone can outline what leronlimab does and what it's capable of across a wide variety of diseases it's Dr. Lalezari. But will the FDA listen?